vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $34.3M, roughly 1.4× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -4.8%, a 3.0% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-2.4M). Over the past eight quarters, Clearfield, Inc.'s revenue compounded faster (-3.5% CAGR vs -20.2%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
CLFD vs IRWD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $47.7M |
| Net Profit | $-614.0K | $-2.3M |
| Gross Margin | 33.2% | — |
| Operating Margin | -5.3% | 14.3% |
| Net Margin | -1.8% | -4.8% |
| Revenue YoY | -3.2% | -47.3% |
| Net Profit YoY | 67.8% | -200.9% |
| EPS (diluted) | $-0.04 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $47.7M | ||
| Q3 25 | $23.4M | $122.1M | ||
| Q2 25 | $49.9M | $85.2M | ||
| Q1 25 | $47.2M | $41.1M | ||
| Q4 24 | $29.7M | $90.5M | ||
| Q3 24 | $5.6M | $91.6M | ||
| Q2 24 | $48.8M | $94.4M | ||
| Q1 24 | $36.9M | $74.9M |
| Q4 25 | $-614.0K | $-2.3M | ||
| Q3 25 | $-9.1M | $40.1M | ||
| Q2 25 | $1.6M | $23.6M | ||
| Q1 25 | $1.3M | $-37.4M | ||
| Q4 24 | $-1.9M | $2.3M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | $-447.0K | $-860.0K | ||
| Q1 24 | $-5.9M | $-4.2M |
| Q4 25 | 33.2% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 30.5% | — | ||
| Q1 25 | 30.1% | — | ||
| Q4 24 | 29.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 7.7% | — |
| Q4 25 | -5.3% | 14.3% | ||
| Q3 25 | 10.3% | 61.8% | ||
| Q2 25 | 3.0% | 53.2% | ||
| Q1 25 | 0.6% | -70.7% | ||
| Q4 24 | -6.9% | 34.8% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | -4.7% | 26.5% | ||
| Q1 24 | -26.4% | 14.7% |
| Q4 25 | -1.8% | -4.8% | ||
| Q3 25 | -38.8% | 32.8% | ||
| Q2 25 | 3.2% | 27.7% | ||
| Q1 25 | 2.8% | -90.9% | ||
| Q4 24 | -6.4% | 2.5% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | -0.9% | -0.9% | ||
| Q1 24 | -16.0% | -5.6% |
| Q4 25 | $-0.04 | $0.01 | ||
| Q3 25 | $-0.65 | $0.23 | ||
| Q2 25 | $0.11 | $0.14 | ||
| Q1 25 | $0.09 | $-0.23 | ||
| Q4 24 | $-0.13 | $0.03 | ||
| Q3 24 | — | $0.02 | ||
| Q2 24 | $-0.04 | $-0.01 | ||
| Q1 24 | $-0.40 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $-261.8M |
| Total Assets | $268.1M | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $215.5M | ||
| Q3 25 | $106.0M | $140.4M | ||
| Q2 25 | $117.2M | $92.9M | ||
| Q1 25 | $112.0M | $108.5M | ||
| Q4 24 | $113.0M | $88.6M | ||
| Q3 24 | $129.0M | $88.2M | ||
| Q2 24 | $123.8M | $105.5M | ||
| Q1 24 | $142.9M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | $2.2M | $198.8M | ||
| Q2 24 | $2.1M | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $249.7M | $-261.8M | ||
| Q3 25 | $256.2M | $-264.2M | ||
| Q2 25 | $264.5M | $-308.2M | ||
| Q1 25 | $265.9M | $-334.1M | ||
| Q4 24 | $267.4M | $-301.3M | ||
| Q3 24 | $275.8M | $-311.3M | ||
| Q2 24 | $274.6M | $-321.7M | ||
| Q1 24 | $279.2M | $-330.5M |
| Q4 25 | $268.1M | $396.9M | ||
| Q3 25 | $306.2M | $396.1M | ||
| Q2 25 | $314.7M | $342.9M | ||
| Q1 25 | $310.9M | $327.2M | ||
| Q4 24 | $303.2M | $350.9M | ||
| Q3 24 | $315.3M | $389.5M | ||
| Q2 24 | $318.1M | $395.6M | ||
| Q1 24 | $315.4M | $438.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $74.6M |
| Free Cash FlowOCF − Capex | $-2.4M | $74.6M |
| FCF MarginFCF / Revenue | -7.1% | 156.3% |
| Capex IntensityCapex / Revenue | 2.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | $7.9M | $-15.1M | ||
| Q1 25 | $3.0M | $20.0M | ||
| Q4 24 | $7.2M | $15.2M | ||
| Q3 24 | $22.2M | $9.9M | ||
| Q2 24 | $4.0M | $33.5M | ||
| Q1 24 | $-5.7M | $45.0M |
| Q4 25 | $-2.4M | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | $7.5M | $-15.1M | ||
| Q1 25 | $654.0K | $19.9M | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $18.2M | $9.9M | ||
| Q2 24 | $2.8M | $33.4M | ||
| Q1 24 | $-7.7M | $44.9M |
| Q4 25 | -7.1% | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | 15.1% | -17.7% | ||
| Q1 25 | 1.4% | 48.4% | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 323.0% | 10.8% | ||
| Q2 24 | 5.8% | 35.4% | ||
| Q1 24 | -20.8% | 60.0% |
| Q4 25 | 2.9% | 0.0% | ||
| Q3 25 | 2.0% | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | 5.1% | 0.1% | ||
| Q4 24 | 7.0% | 0.0% | ||
| Q3 24 | 71.4% | 0.0% | ||
| Q2 24 | 2.5% | 0.1% | ||
| Q1 24 | 5.3% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | 4.93× | -0.64× | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
